Dr. Gillies Grants and Patents


 


 


 


 

Patents


13MB047PRWOUS

Systems, Methods, and Devices for Analyzing Quantitative Information Obtained from Radiological Images

August 1, 2017


11MA026PRWOUS

Method of Screening for Colon Cancer Using Biomarkers

November 8, 2016


10MB069PRWOUS

Melanocortin 1 Receptor Ligands and Methods of Use

September 13, 2016


11MA035PRWOUS

Transient Hypoxia Inducers and Their Use

August 2, 2016


6,596,258:

Method of obtaining extracellular and intracellular pH images and spectra by magnetic resonance using extrinsic indicators containing 1H or 19F, July 22, 2003


 Provisional Docketed:

Hyperpolarized deutero 3-APP imaging agent


 Provisional Docketed:

Combination of TH-302 with a vasodilators (or a pH buffer)


Provisional, Number UA07-022:

Cell Surface Targets for the Development of Diagnostic, Imaging and Therapeutic Agents for Pancreatic Cancer


Provisional Docketed 080902-79 & 080903-79, 2008:

Method of Identifying pancreatic cancer cells


Invention Disclosure Docketed 09MB048:

Non-volatile buffers as inhibitors of metastasis and cancer spread


Invention Disclosure Docketed 10MA024:

Targeted method for non-invasive detection of breast cancer in lymph nodes


Provisional Application Docketed 10MA024PR2:

Non-invasive Detection of Breast Cancer Lymph Node Metastasis using Carbonic Anhydrases IX and XII Targeted Imaging Probes


Provisional, Docketed 11MA026PR:

Identification and validation of surrogate markers for colon adenoma and adenocarcinoma


Provisional Docketed 10MB069PR:

Melanocortin 1 Receptor Ligand-Micelle Complexes and Methods of Use


61/478,465:

Transient Hypoxia Inducers and Their Use


13/479,638:

Method of Increasing Intratumoral pHe and Reducing Acid-Mediated Invasion


60/401,212:

Multivalent Constructs for Use in Biomarker Imaging


13/813,605:

Molecular Imaging of Cancer Cells in vivo


61/618,144:

Molecular Imaging Probe and Method of Melanoma Detection Using Targeted Molecular Imaging Agents


61/644,828:

Molecular Imaging Probes for Lung Cancer Intraoperative Guidance


14/117,949:

Melanocortin 1 Receptor Ligands and Methods of Use


14/041,296:

Method of Screening for Colon Cancer Using Biomarkers


14/112,906:

Transient Hypoxia Inducers and Their Use


14/240,305:

Molecular Imaging of Cancer Cells in Vivo


61/754,140:

Quantitative Predictors of Survival in Lung Adenocarcinoma


60/865,544:

Systems, Methods and Devices for Analyzing Quantitative Information Obtained from Radiological Images


61/890,217:

Systems and Methods for Diagnosing Tumors in a Subject by Performing a Quantitative Analysis of Texture-Based Features of a Tumor Object in a Radiological Image

Grants


NIH/NCI

2P30 CA076292    

(PI: Sellers)

02/01/2012 – 01/31/2022

Moffitt Cancer Center Support Grant


NIH/NCI

1U54CA193489-01A1

(Gatenby, Gillies, Anderson) 

09/23/2015 – 08/31/2020                                                                   

Cancer as a complex adaptive system


NIH/NCI

5R01 CA077575-17 (Gillies)                          

07/01/1999 – 07/31/2019                                                                   

Causes and Consequences of Acid pH in Tumors


NIH/NCI

1R01CA190105-03

(Gillies)                                       

09/19/2014 – 08/31/2018                                                                   

(PQC4) Habitats in Prostate Cancer


NIH/NCI

1R01CA187532-01A1

(Gillies, Martinez)                  

04/01/2015 – 03/31/2020                                                                   

Imaging Habitats in Sarcoma


NIH/NCI

1U0CA200464-01

(Lee, Gillies, Heine, Schabath)    

11/07/2016 – 03/31/2017                                                                   

Moffitt Imaging Biomarker Validation Center


NIH/NCI         

2U01CA143062-06A1

(Gillies, Schabath)                 

12/21/2016 – 07/31/2021                                                                   

Radiomics of NSCLC


V Foundation for Cancer Research - Project D2016-004

(PI: Gatenby, [Gillies Co-Investigator])                              

02/01/2016 – 01/31/2018

Combining targeted therapy and immunotherapy as an evolutionary double bind to optimize treatment in esophageal cancer


NIH/NCI                                                                

U01 CA202958-01    

(PI: Basanta, Lynch, [Gillies Co-Investigator])              

06/08/2016 - 05/31/2021                                                                   

“Multi-Scale Modeling of Bone Environment Responses to Metastatic Prostate Cancer”


Florida Department of Health, Bankhead-Coley Cancer Research Program

8BC04

(PI: Gillies, Pillai)

2018-2020

"Targeting the lipogenic phenotype induced by extracellular acidosis in breast cancer"


 

 

Gillies & Gatenby subcontracts


 

NIH/NCI

1U01CA18614501A1

(Massion)                                

08/03/2015 – 07/31/2020

Non-invasive evaluation of indeterminate pulmonary nodules

Gillies’ Role: PI, Moffitt subcontract


 

NIH/NCI                                                        

1U01CA196405-01

(Massion)                                   

09/24/2015 – 08/31/2020

Cellular, Molecular and Quantitative Imaging Analysis of Screening-Detected Lung Adenocarcinoma

Gillies’ Role: PI, Moffitt subcontract


NIH/NCI

R01CA189295 (PI: Pollack)                                      

08/01/2014 - 07/31/2019

MRI Imaging and Genetic Signatures to Manage Prostate Cancer Overdiagnosis

Gillies’ Role: PI, Moffitt subcontract


NIH/NCI

U24CA180927-01A1 (PI: Rosen)                              

09/01/2014 – 08/31/2019       

Informatics Tools for Optimized Imaging Biomarkers for Cancer Research & Discovery

Gillies’ Role: PI, Moffitt subcontract